← Leaderboards
Steven M Holland
Rockefeller University
$1,634,097
Attributed
$4,024,904
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $747.9K · FY2013–20$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$4,024,904 · 3
By mechanism
U01$4,024,904 · 3
Top collaborators
- John N Galgiani4 shared
- Yves A Lussier4 shared
- Donna L Bratton3 shared
- Jean-Laurent Casanova3 shared
Most similar at Rockefeller University
Same institution · by research overlap
- Arturo Alvarez-Buylla$25,706,636
- Jean-Laurent Casanova$36,806,361
- Anne Puel$1,017,000
- Donald Wells Pfaff$9,213,139
- James G Krueger$4,444,811
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseUnited States National Institutes Of HealthInfectionMutationReportingPathway InteractionsSyndromeInheritedIn VitroGeneticIn VivoSkinTissuesNovel StrategiesMonocyteProductionAutoimmunityFungusImmunologic Deficiency SyndromesInsightPublic HealthArizonaAccountingCenters For Disease Control And Prevention (U.S.)
Grant awards (10)
Immuno-Genetic Basis for Human Disseminated Coccidioidomycosis$563,465
U01 · FY2020 · AI
Treatment of CGD with the PPAR-gamma agonist, pioglitazone, enhances phagocyte anti-inflammatory and antimicrobial responses$168,825
U01 · FY2020 · AI
Immuno-Genetic Basis for Human Disseminated Coccidioidomycosis$579,122
U01 · FY2019 · AI
Treatment of CGD with the PPAR-gamma agonist, pioglitazone, enhances phagocyte anti-inflammatory and antimicrobial responses$168,825
U01 · FY2019 · AI
Immuno-Genetic Basis for Human Disseminated Coccidioidomycosis$553,659
U01 · FY2018 · AI
Treatment of CGD with the PPAR-gamma agonist, pioglitazone, enhances phagocyte anti-inflammatory and antimicrobial responses$166,582
U01 · FY2018 · AI
Immuno-Genetic Basis for Human Disseminated Coccidioidomycosis$573,884
U01 · FY2017 · AI
Molecular, immunological, and clinical dissection of STAT1 hypermorphic mutations$409,876
U01 · FY2015 · AI
Molecular, immunological, and clinical dissection of STAT1 hypermorphic mutations$416,916
U01 · FY2014 · AI
Molecular, immunological, and clinical dissection of STAT1 hypermorphic mutations$423,750
U01 · FY2013 · AI